We are proud to announce that our R&D project leveraging Brain-Computer Interface (BCI) technology has been accepted into the FY2026 “Translational Research Program” by the Japan Agency for Medical Research and Development (AMED).
This project will proceed as an investigator-initiated clinical trial to evaluate the efficacy and safety of an innovative neurorehabilitation system for severe stroke-related upper limb motor deficits. The initiative is supported by Hokkaido University as the designated supporting institution, with Professor Masahiko Mukaino of Hokkaido University serving as the Principal Investigator.

Read the full announcement (Japanese only):
https://www.amed.go.jp/koubo/03007/01/C_00001.html